Literature DB >> 16998497

Modifiers of risk of hereditary breast cancer.

S A Narod1.   

Abstract

Mutations in the BRCA1 and BRCA2 genes confer a high lifetime risk of breast and ovarian cancer. The risk varies from individual to individual, and it appears that the risk has increased in recent generations. These observations imply that non-genetic factors may modify the inherited risk. To date, the factors that appear most strongly to modify the risk include reproductive histories and exogenous hormones. Oral contraceptives are associated with a profound reduction in the risk of ovarian cancer, and with little or no increase in the risk of breast cancer. Other modifying factors include age of menarche, parity, breastfeeding and oophorectomy. The effect of parity is different in BRCA1 and BRCA2 carriers. Multiparity appears to be protective in BRCA1 carriers, but is associated with an increase in risk in BRCA2 carriers. Oophorectomy has been associated with reductions in both the risk of breast and ovarian cancer. Knowledge of these risk factors will be useful for managing risk and for developing prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998497     DOI: 10.1038/sj.onc.1209870

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  BRCA1/2 mutations, fertility and the grandmother effect.

Authors:  Jack da Silva
Journal:  Proc Biol Sci       Date:  2012-05-09       Impact factor: 5.349

Review 2.  Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.

Authors:  Jane E Visvader
Journal:  Genes Dev       Date:  2009-11-15       Impact factor: 11.361

3.  Dose-response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial.

Authors:  Kathryn H Schmitz; Nancy I Williams; Despina Kontos; Susan Domchek; Knashawn H Morales; Wei-Ting Hwang; Lorita L Grant; Laura DiGiovanni; Domenick Salvatore; Desire' Fenderson; Mitchell Schnall; Mary Lou Galantino; Jill Stopfer; Mindy S Kurzer; Shandong Wu; Jessica Adelman; Justin C Brown; Jerene Good
Journal:  Breast Cancer Res Treat       Date:  2015-10-28       Impact factor: 4.872

4.  Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.

Authors:  Marte Myhre Reigstad; Ritsa Storeng; Tor Åge Myklebust; Nan Birgitte Oldereid; Anne Katerine Omland; Trude Eid Robsahm; Louise Annette Brinton; Siri Vangen; Kari Furu; Inger Kristin Larsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-20       Impact factor: 4.254

5.  Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.

Authors:  Jane C Figueiredo; Jennifer D Brooks; David V Conti; Jenny N Poynter; Sharon N Teraoka; Kathleen E Malone; Leslie Bernstein; Won D Lee; David J Duggan; Ashley Siniard; Patrick Concannon; Marinela Capanu; Charles F Lynch; Jørgen H Olsen; Robert W Haile; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2010-12-15       Impact factor: 4.872

6.  Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families.

Authors:  Patrizia Pasanisi; Eleonora Bruno; Elisabetta Venturelli; Siranoush Manoukian; Monica Barile; Bernard Peissel; Clelia De Giacomi; Bernardo Bonanni; Jacopo Berrino; Franco Berrino
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

7.  Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.

Authors:  Emily A Nizialek; Charissa Peterson; Jessica L Mester; Erinn Downes-Kelly; Charis Eng
Journal:  Hum Mol Genet       Date:  2013-02-27       Impact factor: 6.150

8.  The Dose-Response Effects of Aerobic Exercise on Body Composition and Breast Tissue among Women at High Risk for Breast Cancer: A Randomized Trial.

Authors:  Justin C Brown; Despina Kontos; Mitchell D Schnall; Shandong Wu; Kathryn H Schmitz
Journal:  Cancer Prev Res (Phila)       Date:  2016-04-20

9.  Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.

Authors:  Rodrigo Santa Cruz Guindalini; Andrew Song; James D Fackenthal; Olufunmilayo I Olopade; Dezheng Huo
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860

10.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.

Authors:  Elgene Lim; François Vaillant; Di Wu; Natasha C Forrest; Bhupinder Pal; Adam H Hart; Marie-Liesse Asselin-Labat; David E Gyorki; Teresa Ward; Audrey Partanen; Frank Feleppa; Lily I Huschtscha; Heather J Thorne; Stephen B Fox; Max Yan; Juliet D French; Melissa A Brown; Gordon K Smyth; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.